Keyword Analysis & Research: epclusa

Keyword Analysis


Keyword CPC PCC Volume Score Length of keyword
epclusa1.490.97650727

Keyword Research: People who searched epclusa also searched

Keyword CPC PCC Volume Score
epclusa1.320.8837269

Search Results related to epclusa on Search Engine

  • Epclusa: Uses, Dosage, Side Effects & Warnings - Drugs.com

    drugs.com

    https://www.drugs.com/epclusa.html

    WEBApr 12, 2024 · Epclusa is an antiviral treatment for chronic hepatitis C in adults and children 3 years of age and older. Epclusa is a once-a-day medicine containing two antiviral medicines, sofosbuvir and velpatasvir. Epclusa helps stop the hepatitis C virus (HCV) from multiplying in the body by blocking a protein in the virus called HCV NS5.

    DA: 72 PA: 86 MOZ Rank: 69

  • EPCLUSA® (sofosbuvir/velpatasvir) A Treatment Option | Patient …

    epclusa.com

    https://www.epclusa.com/

    WEBEPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1-6 infection with or without cirrhosis (compensated). In those with advanced cirrhosis (decompensated), EPCLUSA is used with ribavirin.

    DA: 47 PA: 68 MOZ Rank: 29

  • Epclusa oral: Uses, Side Effects, Interactions, Pictures ... - WebMD

    webmd.com

    https://www.webmd.com/drugs/2/drug-172068/epclusa-oral/details

    WEBEpclusa - Uses, Side Effects, and More. Generic Name: sofosbuvir-velpatasvir. This medication is a combination of sofosbuvir and velpatasvir and is used to treat chronic (long-lasting) hepatitis...

    DA: 50 PA: 92 MOZ Rank: 46

  • Epclusa: Side Effects, Cost, Dosage, Use for Hep C, and More - Healthline

    healthline.com

    https://www.healthline.com/health/drugs/epclusa

    WEBJun 22, 2022 · Epclusa is an antiviral medication that contains two active drugs: sofosbuvir and velpatasvir. A combination drug made with sofosbuvir and velpatasvir is also available in a generic form....

    DA: 70 PA: 52 MOZ Rank: 35

  • Why EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg)?

    epclusa.com

    https://www.epclusa.com/why-epclusa

    WEBEPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1-6 infection with or without cirrhosis (compensated). In those with advanced cirrhosis (decompensated), EPCLUSA is used with ribavirin.

    DA: 76 PA: 38 MOZ Rank: 73

  • Epclusa (Sofosbuvir & Velpatasvir): Uses & Side Effects - Cleveland Clinic

    clevelandclinic.org

    https://my.clevelandclinic.org/health/drugs/20582-sofosbuvir-velpatasvir-oral-tablets

    WEBEpclusa® is a brand of sofosbuvir and velpatasvir that comes in a tablet form. This antiviral medication treats hepatitis C. Hepatitis C is a viral infection that affects your liver. It causes inflammation and swelling, which damages your liver tissues over time.

    DA: 75 PA: 73 MOZ Rank: 40

  • FDA approves Epclusa for treatment of chronic Hepatitis C virus

    fda.gov

    https://www.fda.gov/news-events/press-announcements/fda-approves-epclusa-treatment-chronic-hepatitis-c-virus-infection

    WEB888-INFO-FDA. The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For ...

    DA: 17 PA: 73 MOZ Rank: 45

  • EPCLUSA® Frequently Asked Questions | Patient Site

    epclusa.com

    https://www.epclusa.com/faq

    WEBEPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C ( Hep C) genotype 1, 2, 3, 4, 5, or 6 infection with or without cirrhosis (compensated). In those with advanced cirrhosis (decompensated), EPCLUSA is used with ribavirin. Speak with your healthcare provider to find out if EPCLUSA is right for you.

    DA: 54 PA: 40 MOZ Rank: 7

  • Sofosbuvir/velpatasvir - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/Sofosbuvir/velpatasvir

    WEBSofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults. It combines sofosbuvir and velpatasvir. It is more than 90% effective for hepatitis C genotypes one through six.

    DA: 29 PA: 49 MOZ Rank: 82

  • Epclusa | European Medicines Agency

    europa.eu

    https://www.ema.europa.eu/en/medicines/human/EPAR/epclusa

    WEBEpclusa is an antiviral medicine used to treat patients from 3 years of age with chronic (long-term) hepatitis C, an infectious disease that affects the liver, caused by the hepatitis C virus. Hepatitis C virus occurs in several varieties (genotypes), and Epclusa can be used to treat hepatitis C caused by all genotypes of the virus.

    DA: 64 PA: 15 MOZ Rank: 16